A 109.67 (-5.45%)
US00846U1016Medical Diagnostics & ResearchDiagnostics & Research

Agilent Technologies (A) Competitor Comparison

We are evaluating the key criteria listed to compare Agilent Technologies (A) against its competitors in the Diagnostics & Research industry.

Performance 10 years - A ranking 15 / 58

These are the competitors of Agilent Technologies in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.47K
3. Medpace Holdings MEDP
1.01K
4. Natera NTRA
699.67
5. RadNet RDNT
497.82
6. IDEXX Laboratories IDXX
439.04
7. DexCom DXCM
345.66
8. Thermo Fisher Scientific TMO
271.62
9. Mettler-Toledo MTD
263.42
10. Danaher DHR
260.32
11. PerkinElmer PKI
247.07
12. CareDx CDNA
220.14
13. Twist Bioscience TWST
210.46
14. Waters WAT
190.56
15. Agilent Technologies A
181.05
16. IQVIA Holdings IQV
161.02
17. Icon ICLR
152.46
18. Quest Diagnostics DGX
118.08
19. Syneos Health SYNH
113.83
20. Laboratory Corp of America Holdings LH
110.54
21. NeoGenomics NEO
101.26
22. Charles River Laboratories CRL
94.92
23. Exact Sciences EXAS
93.87
24. Fulgent Genetics FLGT
85.12
25. Meridian Bioscience VIVO
60.69
26. Guardant Health GH
55.46
27. Qiagen QGEN
52.55
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Inotiv NOTV
5.39
30. National Research NRC
-7.79
31. Anixa Biosciences ANIX
-8.62
32. Olink Holding OLK
-26.82
33. Bioventus BVS
-40.2
34. Neogen NEOG
-51.09
35. Sotera Health SHC
-56.41
36. Illumina ILMN
-56.45
37. Global Cord Blood CO
-66.57
38. Myriad Genetics MYGN
-75.23
39. DarioHealth DRIO
-75.47
40. Sera Prognostics SERA
-76.42
41. Exagen XGN
-77.14
42. Enzo Biochem ENZ
-77.8
43. Pacific Biosciences of California PACB
-79.72
44. Co-Diagnostics CODX
-83.5
45. MaxCyte MXCT
-83.93
46. Personalis PSNL
-84.66
47. Psychemedics PMD
-85.98
48. MDxHealth MDXH
-87.57
49. bioAffinity Technologies BIAF
-88.45
50. Biodesix BDSX
-92.64
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-96.66
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Trinity Biotech TRIB
-98.9
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.49
58. Precipio PRPO
-99.76

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.